Last updated: 2026-10-12 15:25:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Ascendis Pharma A/S (ASND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $227,90, with a market capitalization of $15,08B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $186,05 to $282,15. This page covers its latest market performance, valuation, price trends and company information.
$15,08B | |
$229,00 | |
$282,15 | |
$11,92 | |
$229,23 | |
54,39K | |
670,84K | |
-- | |
$282,15 | |
$186,05 | |
-- | |
-- |
Ascendis Pharma A/S (ASND) is currently trading at $227,90 as of 2026-10-12 15:23:00, down 0,58% ($1,33) from the previous close of $229,23
During today's regular trading session, ASND has traded between $11,92 and $282,15, with a trading volume of 54,39K shares. The current price is near the upper end of today's range.
Over the past seven days, Ascendis Pharma A/S (ASND) moved from $227,31 to $227,90, representing a gain of 0,26% ($0,59).
The stock traded between $219,52 and $233,96 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 840,50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 43,5%
ASND is currently trading at $227,90, placing it 43,5% of the way from its 52-week low of $186,05 to its 52-week high of $282,15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
| Employees | 1189 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Ascendis Pharma A/S (ASND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.